Retrospective study highlights diagnosis and effective surgical and imatinib treatment for GISTs, implying improved patient outcomes.
Key Points
Gastrointestinal stromal tumors often present with abdominal pain and deteriorated general condition, impacting quality of life.
Among 16 cases, the average patient age was 56 years and tumors primarily localized in the stomach, emphasizing site-specific challenges.
Surgical intervention, including laparotomy, was performed for 14 patients, revealing the importance of effective multidisciplinary diagnosis and management.
First-line therapies, including imatinib and surgery, have shown revolutionary effectiveness, suggesting a promising future for GIST patients.